Literature DB >> 14643849

Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence.

Gery Schulteis1, Andrew C Morse, Jian Liu.   

Abstract

Single injections with morphine can induce a state of acute opioid dependence in humans and animals, typically measured as precipitated withdrawal when an antagonist such as naloxone is administered 4-24 h after morphine. Repeated treatment with morphine at 24-h intervals can result in a progressive shift in potency of naloxone to produce such acute withdrawal signs, including suppression of operant responding for food reward. The current study characterized fully both morphine and naloxone dose-effect functions in an effort to establish the relative contributions of repeated morphine vs. repeated naloxone (Nal) experience to these potency shifts. Rats trained on an FR15 schedule for food received four vehicle or morphine injections (0.56-5.6 mg/kg sc), spaced 24 h apart. Four hours after each morphine pretreatment (Repeat Nal), or 4 h after the fourth and final morphine pretreatment only (Single Nal), a cumulative dose-effect function for naloxone-induced suppression of responding was determined. Vehicle-pretreated (Morphine Naive) rats showed little change in the naloxone dose effect function even after four cumulative dose-effect determinations. By contrast, a progressive increase in naloxone potency was observed following successive pretreatments with morphine under Repeat Nal conditions, and the magnitude of naloxone potency shift was morphine dose dependent. At a morphine dose of 5.6 mg/kg, repeated naloxone experience in the presence of morphine was not an absolute requirement to produce an increase in naloxone potency across days, but repeated naloxone could potentiate the magnitude of the observed shift, indicating both experience-independent and experience-dependent processes at work. At lower doses of morphine (1.0 and 3.3 mg/kg) no shift in naloxone potency was observed across days of morphine treatment in the absence of repeated naloxone experience (Single Nal conditions), indicating an increasing contribution of naloxone experience-dependent processes as dose of morphine was decreased. It is argued that these experience-dependent processes in the progressive shift of naloxone potency observed in the current study may reflect an important role of conditioning in the early development of opioid dependence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14643849     DOI: 10.1016/j.pbb.2003.09.006

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  16 in total

Review 1.  Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

2.  Context- and cue-conditioned potentiation of acute morphine dependence and withdrawal.

Authors:  Gery Schulteis; Jian Liu; Nurith Amitai; Sally Tzeng
Journal:  Pharmacol Biochem Behav       Date:  2005-08-24       Impact factor: 3.533

3.  Discrete cues paired with naloxone-precipitated withdrawal from acute morphine dependence elicit conditioned withdrawal responses.

Authors:  Nurith Amitai; Jian Liu; Gery Schulteis
Journal:  Behav Pharmacol       Date:  2006-05       Impact factor: 2.293

4.  Rapid neuroadaptation in the nucleus accumbens and bed nucleus of the stria terminalis mediates suppression of operant responding during withdrawal from acute opioid dependence.

Authors:  S H Criner; J Liu; G Schulteis
Journal:  Neuroscience       Date:  2006-12-11       Impact factor: 3.590

5.  Reversal effect of intra-central amygdala microinjection of L-arginine on place aversion induced by naloxone in morphine conditioned rats.

Authors:  Sara Karimi; Manizheh Karami; Hedayat Sahraei; Mahnaz Rahimpour
Journal:  Iran Biomed J       Date:  2011

6.  Tolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats.

Authors:  M H Zissen; G Zhang; A McKelvy; J T Propst; J J Kendig; S M Sweitzer
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

7.  Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.

Authors:  Gery Schulteis; Andrew C Morse; Jian Liu
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

8.  Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake.

Authors:  Anna K Radke; Nathan A Holtz; Jonathan C Gewirtz; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2012-12-20       Impact factor: 4.530

9.  Cellular and behavioral interactions of gabapentin with alcohol dependence.

Authors:  Marisa Roberto; Nicholas W Gilpin; Laura E O'Dell; Maureen T Cruz; Andrew C Morse; George R Siggins; George F Koob
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

10.  Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze.

Authors:  Zhongqi Zhang; Gery Schulteis
Journal:  Pharmacol Biochem Behav       Date:  2008-01-29       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.